News & Updates

Show Multimedia Only
Bimekizumab tops risankizumab on ACR50 in psoriatic arthritis
Bimekizumab tops risankizumab on ACR50 in psoriatic arthritis
30 Jul 2026
Proton therapy for breast cancer reduces cardiopulmonary radiation exposure, with an 8-month 100% survival rate
Proton therapy for breast cancer reduces cardiopulmonary radiation exposure, with an 8-month 100% survival rate
30 Jul 2026